繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
牛牛AI助理已提取核心訊息
FOXO Technologies Inc. (FOXO) reported financial results for the quarter ended June 30, 2024. The company saw an increase in net revenues to $35, up 40% from $25 in the same period last year, primarily due to the acquisition of Myrtle, a behavioral health services provider. Operating expenses decreased by 81% to $2,803, with significant reductions in research and development, management contingent share plan expenses, and selling, general and administrative expenses. The company's net loss improved by 81% to $3,668, compared to a net loss of $18,932 in the prior year. The improvement was attributed to the decrease in operating expenses and non-operating expenses. FOXO's liquidity position remains a concern, with a working capital deficit and total stockholders' deficit of $20,817 and $16,167, respectively. The company has taken steps...Show More
FOXO Technologies Inc. (FOXO) reported financial results for the quarter ended June 30, 2024. The company saw an increase in net revenues to $35, up 40% from $25 in the same period last year, primarily due to the acquisition of Myrtle, a behavioral health services provider. Operating expenses decreased by 81% to $2,803, with significant reductions in research and development, management contingent share plan expenses, and selling, general and administrative expenses. The company's net loss improved by 81% to $3,668, compared to a net loss of $18,932 in the prior year. The improvement was attributed to the decrease in operating expenses and non-operating expenses. FOXO's liquidity position remains a concern, with a working capital deficit and total stockholders' deficit of $20,817 and $16,167, respectively. The company has taken steps to address its capital needs, including entering into stock exchange agreements with RHI to acquire Myrtle and RCHI, a critical care hospital, which are expected to provide positive operating cash flows. However, there is substantial doubt about FOXO's ability to continue as a going concern without securing additional financing. The company's future plans include continuing capital raise initiatives, pursuing strategic acquisitions, and commercializing products to generate revenue.
FOXO Technologies Inc(FOXO)報告了2024年6月30日結束的季度財務業績。該公司的淨收入增至35美元,比去年同期的25美元增長了40%,這主要歸因於其收購行爲健康服務提供商Myrtle。營業費用減少了81%,至2,803美元,其中研究與開發、管理套期股份計劃費用以及銷售、總務以及行政費用的大幅削減起了重要作用。公司的淨虧損率比上一財年下降了81%,至3,668美元,而上一財年的淨虧損率爲18,932美元。這一改善歸因於營業費用和非營業費用的減少。FOXO的流動性仍然是一個問題,出現了營運資本虧損和股東總赤字的情況,分別爲20,817美元和16,167美元。該公司已經採...展開全部
FOXO Technologies Inc(FOXO)報告了2024年6月30日結束的季度財務業績。該公司的淨收入增至35美元,比去年同期的25美元增長了40%,這主要歸因於其收購行爲健康服務提供商Myrtle。營業費用減少了81%,至2,803美元,其中研究與開發、管理套期股份計劃費用以及銷售、總務以及行政費用的大幅削減起了重要作用。公司的淨虧損率比上一財年下降了81%,至3,668美元,而上一財年的淨虧損率爲18,932美元。這一改善歸因於營業費用和非營業費用的減少。FOXO的流動性仍然是一個問題,出現了營運資本虧損和股東總赤字的情況,分別爲20,817美元和16,167美元。該公司已經採取措施來解決其資本需求,包括與RHI簽訂交易所協議,以收購Myrtle和RCHI,一家重症監護醫院,這預計將提供正面的營業現金流。然而,FOXO無法獲得補充融資的情況下,公司的未來存在重大疑慮。該公司的未來計劃包括繼續籌集資金計劃、尋求戰略收購以及推廣產品來產生營業收入。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間